KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Retained Earnings (2016 - 2025)

Resmed (RMD) has disclosed Retained Earnings for 16 consecutive years, with $6.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 21.03% year-over-year to $6.6 billion, compared with a TTM value of $6.6 billion through Dec 2025, up 21.03%, and an annual FY2025 reading of $6.1 billion, up 21.83% over the prior year.
  • Retained Earnings was $6.6 billion for Q4 2025 at Resmed, up from -$60.7 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $6.6 billion in Q4 2025 and bottomed at -$270.2 million in Q4 2022.
  • Average Retained Earnings over 5 years is $2.9 billion, with a median of $3.5 billion recorded in 2022.
  • The sharpest move saw Retained Earnings crashed 108.03% in 2022, then skyrocketed 2735.94% in 2024.
  • Year by year, Retained Earnings stood at $3.4 billion in 2021, then crashed by 108.03% to -$270.2 million in 2022, then rose by 22.88% to -$208.4 million in 2023, then surged by 2735.94% to $5.5 billion in 2024, then grew by 21.03% to $6.6 billion in 2025.
  • Business Quant data shows Retained Earnings for RMD at $6.6 billion in Q4 2025, -$60.7 million in Q3 2025, and $6.1 billion in Q2 2025.